Fig 1.
Study and data analysis flow chart.
We included 599 eligible participants from two cohort studies conducted in Amazonas. Of these, 274 healthy individuals without malaria history in the prior 12 months were included in the “Healthy Group” and 325 patients diagnosed with Pv-malaria infection were included in the “Pv-malaria Cases”. Parasitemia analysis was performed for 208 patients.
Table 1.
Clinical and demographic characteristics of the study population.
Table 2.
Genotype and allele frequencies of the TLRs and CD14 polymorphisms in patients with Pv-malaria and healthy controls.
Table 3.
Association of parasitemia with TLR and CD14 polymorphisms in Pv-malaria patients.